Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth
University of Oulu
Administration of steroid to the mother in imminent preterm delivery is a known effective
practice to decrease the risk of respiratory distress syndrome and intraventricular
haemorrhage in preterm infants if given with a week of the preterm delivery. This randomized
clinical trial is performed to test the possibility whether the repeat dose of steroid
results in further reduction of these diseases in case the mother is in imminent preterm
delivery more than a week after the first antenatal steroid treatment.
Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer
Janssen Research & Development, LLC
Phase 1/Phase 2
The purpose of this study is to evaluate the safety, pharmacokinetics, pharmacodynamics, and
anti‑tumor activities of abiraterone acetate (also referred to as CB7630) in patients with
hormone refractory prostate cancer (HRPC).
UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide
University of Arkansas
Add three drugs, bortezomib, thalidomide, and dexamethasone (VTD) to the high dose
chemotherapy regimen immediately before transplant (DPACE/Melphalan) to try to improve
myeloma response and acquire longer survival for participants.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.